Corrigendum to “Effect of sodium ferulate on the hyperalgesia mediated by P2X3 receptor in the neuropathic pain rats” (Effect of sodium ferulate on the hyperalgesia mediated by P2X”3 receptor in the neuropathic pain rats (2010) 1313 (215–221), (S0006899309025864), (10.1016/j.brainres.2009.11.067));Effect of sodium ferulate on the hyperalgesia mediated by P2X3 receptor in the neuropathic pain rats

Brain Research

Volumn 1313, Issue , 2010, Pages 215-221

  Zhang, Aixia ^a   Gao, Yun ^a   Zhong, Xiaoqin ^a   Xu, Changshui ^a   Li, Guilin ^a   Liu, Shuangmei ^a   Lin, Jiari ^a   Li, Xin ^a   Zhang, Yun ^a   Liu, Han ^a   Linag, Shangdong ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Dorsal root ganglion; Neuropathic pain; Sodium ferulate

Indexed keywords

FERULIC ACID; PURINERGIC P2X3 RECEPTOR; SODIUM CHLORIDE;

0MECHANICAL HYPERALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LATENT PERIOD; MALE; MECHANICAL HYPERALGESIA; MECHANICAL STIMULATION; NERVE COMPRESSION; NERVE INJURY; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RAT; SENSORY NERVE CELL; SENSORY NERVE CONDUCTION; SPINAL CORD NERVE CELL; SPINAL GANGLION; THERMAL HYPERALGESIA; THERMAL STIMULATION; UPREGULATION; WESTERN BLOTTING; WITHDRAWAL REFLEX;

RATTUS;

EID: 74149083366     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2019.03.032     Document Type: Erratum

References (49)

1. Backonja M.M. Defining neuropathic pain. Anesth. Analg. 97 (2003) 785-790
2. Bennett G.J., and Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33 (1988) 87-107
3. Bleehen T., and Keele C.A. Observation on the algogenic actions of adenosine compounds on the human blister base preparation. Pain 3 (1977) 367-377
4. Bodin P., and Burnstock G. Purinergic signalling: ATP release. Neurochem. Res. 26 (2001) 959-969
5. Burnstock G. The past, present and future of purine nucleotides as signaling molecules. Neuropharmacology 36 (1997) 1127-1139
6. Burnstock G. P2X receptors in sensory neurons. B. J. Anaesth. 84 (2000) 476-488
7. Burnstock G. Purinergic P2 receptors as targets for novel analgesics. Pharmacol. Ther. 110 (2006) 433-454
8. Burnstock G. Physiology and pathophysiology of purinergic neurotransmission. Physiol. Rev. 879 (2007) 659-797
9. Burnstock G. Purinergic receptors and pain. Curr. Pharm. Design 15 (2009) 1717-1735
10. Burnstock G., and Wood J.N. Purinergic receptors: their role in nociception and primary afferent neurotransmission. Curr. Opin. Neurobiol. 6 (1996) 526-532
11. 3 receptor in neuropathic pain states. Brain Res. Bull. 77 (2008) 27-32
12. Chen, Y., Li, G.W., Wang, C., Gu, Y., Huang, L.Y., 2005. Mechanisms underlying enhanced P2X receptor-mediated responses in the neuropathic pain state. 119, 38-48.
13. Chizh B.A., and Illes P. P2X receptors and nociception. Pharmacol. Rev. 53 (2001) 532-681
14. Christoph T., Gillen C., Mika J., Grünweller A., Schäfer M.K., Schiene K., Frank R., Jostock R., Bahrenberg G., Weihe E., Erdmann V.A., and Kurreck J. Antinociceptive effect of antisense oligonucleotides against the vanilloid receptor VR1/TRPV1. Neurochem. Int. 50 (2007) 281-290
15. Cockayne D.A., Hamilton S.G., Zhu Q.M., Dunn P.M., Zhong Y., Novakovic S., Malmberg A.B., Cain G., Berson A., Kassotakis L., Hedley L., Lachnit W.G., Burnstock G., McMahon S.B., and Ford A.P. Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 407 (2000) 1011-1015
16. Donnelly-Roberts D., McGaraughty S., Shieh C.C., Honore P., and Jarvis M.F. Painful purinergic receptors. J. Pharmacol. Exp. Ther. 324 (2008) 409-415
17. Dunn P.M., Zhong Y., and Burnstock G. P2X receptors in peripheral neurons. Prog. Neurobiol. 65 (2001) 107-134
18. Dussora G., Koerbere H.R., Oaklanderb A.L., Ricec F.L., and Molliverd D.C. Nucleotide signaling and cutaneous mechanisms of pain transduction. Brain Res. Rev. 60 (2009) 24-35
19. Fujita R., Kiguchi N., and Ueda H. LPA-mediated demyelination in ex vivo culture of dorsal root. Neurochem. Int. 50 (2007) 351-355
20. Fang C.H., Liu S.P., Dong W.G., and Yu J.P. Effects of sodium ferulate on function of macrophages in the colonic tissue of colitis rats. Chin. J. Gastroenterol. Hepatol. 15 (2006) 116-118
21. Hamilton S.G., Warburton J., Bhattacharjee A., Ward J., and McMahon S.B. ATP in human skin elicits a dose-related pain response under conditions of hyperalgesia. Brain 123 (2000) 1238-1246
22. Hamilton S.G., McMahon S.B., and Lewin G.R. Selective activation of nociceptors by P2X receptor agonists in normal and inflamed rat skin. J. Physiol. 534 (2001) 437-445
23. Jarvis M.F., Burgard E.C., McGaraughty S., Honore P., Lynch K., Brennan T.J., Subieta A., Van Biesen T., Cartmell J., Bianchi B., Niforatos W., Kage K., Yu H., Mikusa J., Wismer C.T., Zhu C.Z., Chu K., Lee C.H., Stewart A.O., Polakowski J., Cox B.F., Kowaluk E., Williams M., Sullivan J., and Faltynek C. A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 17179-17184
24. Kennedy C. P2X receptors: targets for novel analgesics. Neuroscientist 11 (2005) 345-356
25. Kennedy C., Assis T.S., Currie A.J., and Rowan E.G. Crossing the pain barrier: P2 receptors as targets for novel analgesics. J. Physiol. 553 (2003) 683-694
26. Khakh B.S., Smith W.B., Chiu C.S., Ju D., Davidson N., and Lester H.A. Molecular physiology of P2X receptors and ATP signalling at synapses. Nat. Rev., Neurosci. 98 (2001) 65-174
27. Lecca D., and Abbracchio M.P. Deorphanisation of G protein-coupled receptors: a tool to provide new insights in nervous system pathophysiology and new targets for psycho-active drugs. Neurochem. International 52 3 (2008) 339-351
28. Liang S.D., Gao Y., Xu C.S., Xu B.H., and Mu S.N. Effect of tetramethylpyrazine on acute nociception mediated by signaling of P2X receptor activation in rat. Brain Res. 995 (2004) 247-252
29. Liang S.D., Xu C.S., Zou T., Liu H.Q., Gao Y., and Li G.L. Tetramethylpyrazine inhibits ATP-activated currents in rat dorsal root ganglion neurons. Brain Res. 1040 (2005) 92-97
30. Liu H.R. Pharmacological action and clinical application of sodium ferulate. China Pharm. 14 (2005) 78-79
31. Liu X.J., and Salter M.W. Purines and pain mechanisms: recent developments. Curr. Opin. Investig. Drugs 6 (2005) 65-75
32. Lumpkin E.A., and Caterina M.J. Mechanisms of sensory transduction in the skin. Nature 445 (2007) 858-865
33. Merskrey H. Logic, truth and language in concepts of pain. Qual. Life Res. 3 (1994) 69-76
34. North R.A. Molecular physiology of P2X receptors. Physiol. Rev. 82 4 (2002) 1013-1067
35. 3 receptors and peripheral pain mechanisms. J. Physiol. 2 (2003) 301-308
36. North R.A. The P2X3 subunit: a molecular target in pain therapeutics. Curr. Opin. Investig. Drugs 4 (2003) 833-840
37. Novakovic S.D., Kossotakis L.C., Oglesby I.B., Smith J.A., Eglen R.M., Ford A.P., and Hunter J.C. Immunocytochemical localization of P2X3 purinoceptors in sensory neurons in naïve rats and following neuropathic injury. Pain 80 (1999) 273-282
38. Ozaki Y. Antiinflammatory effect of tetramethylpyrazine and ferulic acid. Chem. Pharm. Bull. 40 (1992) 954-956
39. Payne E. Cancer pain, anatomy, physiology, and pharmacology. Cancer 63 (1989) 2266-2274
40. Przewlocki R., and Przewlocka B. Opioids in neuropathic pain. Curr. Pharm. Des. 11 (2005) 3013-3025
41. Souslova V., Cesare P., Ding Y., Akopian A.N., Stanfa L., Suzuki R., Carpenter K., Dickenson A., Boyce S., Hill R., Nebenuis-Oosthuizen D., Smith A.J., Kidd E.J., and Wood J.N. Warm-coding deficits and aberrant inflammatory pain in mice lacking P2X3 receptors. Nature 407 (2000) 1015-1017
42. Saarto T., and Wiffen P.J. Antidepressants for neuropathic pain. Cochrane Database Syst. Rev. 17 (2007) CD005454
43. Tha'n M., Kocsis P., Tihanyi K., Fodor L., Farkas B., Kova'cs G., Kis-Varga A., Szombathelyi Z., and Tarnawa I. Concerted action of antiepileptic and antidepressant agents to depress spinal neurotransmission: possible use in the therapy of spasticity and chronic pain. Neurochem. Int. 50 (2007) 642-652
44. Tsuda M., Koizumi S., Kita A., Shigemoto Y., Ueno S., and Inoue K. Mechanical allodynia caused by intraplantar injection of P2X receptor agonist in rats: involvement of heteromeric P2X2/3 receptor signaling in capsaicin-insensitive primary afferent neurons. J. Neurosci. 20 15 (2000) RC90
45. Tsuda M., Hasegawa S., and Inoue K. P2X receptors-mediated cytosolic phospholipase A2 activation in primary afferent sensory neurons contributes to neuropathic pain. J. Neurochem. 103 (2007) 1408-1416
46. Tsuzuki K., Ase A., Seguela P., Nakatsuka T., Wang C.Y., She J.X., and Gu J.G. TNP-ATPresistant P2X ionic currents on the central terminals and somata of rat primary sensory neurons. J. Neurophysiol. 89 (2003) 3235-3242
47. Wang B.H., and Ou-Yang J.P. Pharmacological actions of sodium ferulate in cardiovascular system. Cardiovasc. Drug Rev. 23 (2005) 161-172
48. Wirkner K., Sperlagh B., and Illes P. P2X3 receptor involvement in pain states. Mol. Neurobiology 36 (2007) 165-183
49. 3 receptor. Neurochem. Int. 53 6-8 (2008) 278-282